What caused the volume spike for FCG.AX stock on 12 Mar 2026?

The official driver is unclear. The spike to **1,184,838** shares likely reflects block trading or focused buyer interest. Traders should monitor ASX regular-session volume and company announcements for confirmation.

What is Meyka AI's short and 12-month outlook for FCG.AX stock?

Meyka AI's short-term view is cautious; near-term target **A$0.05**. The 12-month model projects **A$0.12**, implying **224.32%** upside from **A$0.037**. Forecasts are model-based and not guarantees.

How risky is investing in Freedom Care Group (FCG.AX)?

Risk is above average because of low market cap **A$4,007,738.00**, thin trading history, and margin volatility. Key risks include NDIS funding shifts and liquidity. Position sizing is advised.

Where can I find live data and peer comparisons for FCG.AX stock?

Use market portals and Meyka AI's live stock page for FCG.AX. For peer comparison see the Investing.com compare tool linked in our analysis and sector commentary on Meyka.

AU Stocks

1,184,838 after-hours for FCG.AX Freedom Care on ASX 12 Mar 2026: watch

ByHuzaifa Zahoor March 12, 2026March 12, 2026

A large after-hours volume spike pushed FCG.AX stock into focus tonight. Volume hit 1,184,838 shares versus an average of 30,060, a 39.42x relative surge that can precede price moves. The price printed A$0.037 (last trade) after an intraday high of A$0.059. We review why this volume matters, what the numbers say about valuation, and where analysts and Meyka AI see the stock headed in the ASX healthcare sector.